A panel of medical professionals will discuss the public health impact of e-cigarette use, or "vaping," today during a session at the annual meeting of the Radiological Society of North America (RSNA).
REYNOLDS AMERICAN INC.: VUSE Premarket Tobacco Product Application Filed for Substantive Review by the FDA
First-of-its-Kind Filing for VUSE Products
Plans have been proposed to increase tax on tobacco, ban electronic vapes and tighten online advertising of cigarettes.
IntelliQuit's Cloud Based Nicotine Bio-Monitoring Measures Nicotine Consumption in Vapers Aiding Treatment
Great American Smoke Out is November 21st
CDC: What young adults need to know about lung injuries associated with the use of e-cigarette or vaping products
Nearly 80% of patients with lung injury related to use of e-cigarette, or vaping, products are younger than 35 years old. More than half are under 25! The Centers for Disease Control and Prevention (CDC) together with state and local health departments and federal partners including the Food and Drug Administration (FDA) continues investigating this national outbreak of lung injury associated with the use of e-cigarette, or vaping, products.
The Land Transportation Franchising and Regulatory Board (LTFRB), heeding the directive of the Department of Health (DOH), has reiterated its ban on smoking cigarettes and e-cigarettes in public utility vehicles (PUVs) amid reports of exploding vaping devices.
ACHIEVE LIFE SCIENCES: Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference
Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that data from the Phase 2b ORCA-1 trial will be presented at the SRNT-O Inaugural Conference.
The U.S. Food and Drug Administration announced today that, for the first time, it has authorized the marketing of products through the modified risk tobacco product (MRTP) pathway.
AMERICAN COLLEGE OF CHEST PHYSICIANS: Smokers have more blood clots in the lung, leading to higher hospital readmission rates
Patients with lung blood clots who smoke are more likely to be readmitted for lung blood clots than nonsmokers, according to Kam Sing Ho, MD, from Mount Sinai St. Luke's and Mount Sinai West in New York City, who will present the study findings at the CHEST Annual Meeting 2019 in New Orleans.
SFATA: Smoke-Free Alternatives Trade Association and Coalition of Vapor Businesses & State Associations Granted Motion to Intervene in American Association of Pediatrics v FDA
Big Win for Vapor Industry: Can Now Appeal PMTA Deadline
American Lung Association and Anthem Foundation Reach More than 10,000 Public Housing Residents with Quit Smoking Support
American Lung Association helps residents affected by smokefree public housing rule break tobacco addiction
The American Association for Respiratory Care (AARC) strongly supports the Administration's announcement on September 11 regarding its plans to remove flavored e-cigarettes from the marketplace and commends its actions to protect our nation's youth from being deceived by the tobacco industry's marketing strategies that have led to the current epidemic of youth e-cigarette and vaping use.
U.S. FDA: Warns JUUL Labs for marketing unauthorized modified risk tobacco products, including in outreach to youth
Agency sends additional letter requesting more information on several issues, including outreach and marketing practices, as part of ongoing investigation
U.S. FDA: Statement from Acting FDA Commissioner Ned Sharpless, M.D., and CDC Director Robert R. Redfield, M.D., on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products
Both the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention are working tirelessly to investigate the distressing incidents of severe respiratory disease associated with use of e-cigarette products
URTHLEAF: Introduces Safe and Disposable CBD Vape Pen for Daily Use: CBD Vape Pen for Anxiety and Relaxation
The CBD Vape Pen is a disposable, battery-operated pen that is both compact and visually satisfying. Containing no THC, UrthLeaf offers the Vape Pen as a wellness product that can be purchased singly or as a monthly subscription. The CBD Vape Pen is available directly from the UrthLeaf website.
Smokeless Edition minimizes second-hand smoke, making it the safest e-cigarette product available in the market
U.S. FDA: Proposes new required health warnings with color images for cigarette packages and advertisements to promote greater public understanding of negative health consequences of smoking
The U.S. Food and Drug Administration issued a proposed ruleto require new health warnings on cigarette packages and in advertisements to promote greater public understanding of the negative health consequences of smoking.
U.S. FDA: Notifies four companies to remove 44 flavored e-liquid and hookah tobacco products from the market for not having required marketing authorization
Agency remains vigilant in investigating and taking action against illegally marketed tobacco products amid epidemic of youth e-cigarette use
AMERICAN CANCER SOCIETY: New Report Highlights Big Tobacco's Dangerous Attempts to Co-opt Promising Public Health Policies to Serve Their Own Agenda
Report Also Finds States Are Missing Opportunities to Reduce Suffering and Death from Cancer by Failing to Pass and Implement Evidence-Based Policies
22ND CENTURY GROUP, INC.: FDA Accepts and Files 22nd Century Group’s Modified Risk Tobacco Product Application for VLN™ Cigarettes
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco harm reduction, announced that the U.S. Food and Drug Administration (FDA) accepted and filed for substantive scientific review the Company’s Modified Risk Tobacco Product (MRTP) application for its exclusive Very Low Nicotine Content (VLNC) cigarettes under the proposed brand name of VLNTM. 22nd Century’s proposed VLNTM cigarettes are made with the Company’s proprietary VLNC tobacco and, as a result, contain very low levels of nicotine.